Higher Sirolimus Levels Between Days 11-20 After Allogeneic Hematopoietic Stem Cell Transplantation (HCT) Increase the Risk of Hepatic Sinusuoidal Obstruction Syndrome (SOS) After Non-Busulfan Myeloablative Conditioning
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.435
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Elsevier BV